EP1455814 - Bibliographic data

PHARMACEUTICAL COMPOSITIONS COMPRISING UNACYLATED GHRELIN FOR USE IN THE TREATMENT OF INSULIN RESISTANCE

Last update 19/07/2025
Legal status Brevet déchu
Origin Euro-PCT

(73) Holder

ALIZÉ PHARMA SAS

15, Chemin du Saquin Espace Européen
69130 Ecully
France
(72) Inventors

GHIGO, Ezio

D`Azeglio 22
10125 Torino
Italie

VAN DER LELY, Aart Jan

Papavertuin 14
NL-2662 CW Bergschenhoek
Pays-Bas
(74) Agent

Mail recipient

REGIMBEAU

139, rue Vendôme
69466
Lyon Cedex 06
France

(21) Request number EP02787266.2
(22) Request date 18/12/2002

(11) Publication number EP1455814
Publication date 04/04/2012

(54) Title of the invention PHARMACEUTICAL COMPOSITIONS COMPRISING UNACYLATED GHRELIN FOR USE IN THE TREATMENT OF INSULIN RESISTANCE
(51) International classification A61P 3/04A61P 3/10A61K 38/27
International classification (before reform) None

Claimed priority

(31) Number: 2365704
(32) Date: 18/12/2001
(33) Country: CA

Initial application None
Divisional application None

Expected annuity Annuity: 11 - Amount: 165 € - Due date 31/12/2012
Surtax: 11 - Amount: 33 € - Due date 01/07/2013
Last annuity None

Publication

BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2012/2, of 30/06/2012

History

Publication de la délivrance du brevet européen - Legal date 04/04/2012


Modification du mandataire OEB du brevet européen - Legal date 05/12/2012


Déchéance du brevet d'invention après période de grâce - Legal date 31/12/2012


Entrée en période de grâce du brevet d'invention - Legal date 31/12/2012